An inner city population of people over 65 years of age was screened using Short CARE in 1987. Eight percent were identified as having possible cognitive impairment and 4.7% as probable pervasive dementia, from the scores on two scales of this interview. A detailed clinical reassessment of these subjects identified by screening suggested a rate of clinical dementia at 6.1 %, 3.1% meeting the criteria for probable Alzheimer''s disease. Two and a half years later, 72% have been rescreened using Short CARE. Fifteen percent of the population had died, 7% moved away and 6% were not available for interview. Thirty-five (5.9%) of the subjects rescreened appeared, from their scores on the two scales, to be new cases of dementia, giving a possible annual incidence rate of 2.6 %. The annual incidence rate of probable pervasive dementia was 1.4%. These subjects are now in the process of having a detailed clinical diagnostic assessment. The medical records of those who had died between the two screens are being checked for evidence of dementia, so that more precise incidence rates can be calculated.

Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.